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Abstract:
Introduction: Oral HPV and oropharyngeal cancer prevalence are 
increasing, particularly in men. Raising greater awareness of male HPV 
disease is perceived as an important intervention strategy. This study 
investigated the effectiveness of HPV education on adolescents’ 
perception of HPV disease and the impact of HPV vaccination on their 
sexual health. 
Methods: A HPV questionnaire was completed by 357 UK-based 
adolescents, aged 12-13 years. 
Results: Most adolescents knew HPV causes cervical cancer and HPV 
vaccination prevents this. A minority acknowledged HPV causes other 
genital cancers, with under a fifth knowing HPV causes genital warts. 
Adolescents  awareness of HPV transmission activities were limited. 
There was very poor awareness of oral HPV infection or HPV-induced 
oropharyngeal cancer. Half of the participants stated HPV vaccination 
reduced their concerns about STI contraction. Over half of males said 
they may take more sexual risks following vaccination, whilst a similar 
proportion of females did not expect their partner to take more risks. 
Conclusions: Adolescents had little awareness of male HPV infection and 
the role HPV vaccination can play in preventing these diseases. With 
variable rates of HPV vaccination uptake in males reported worldwide, 
this study indicates that in the UK greater emphasis on male HPV disease 
within educational information is required, to raise better awareness of 
how HPV affects both genders.  As both genders preferred to receive 
education via healthcare professionals, educating a wider-range of 
healthcare professionals on oral HPV could help facilitate awareness of 
HPV’s role in head and neck cancer.  
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ABSTRACT 
Introduction: Oral HPV and oropharyngeal cancer prevalence are increasing, particularly in 
men. Raising greater awareness of male HPV disease is perceived as an important 
intervention strategy. This study investigated the effectiveness of HPV education on 
adolescents’ perception of HPV disease and the impact of HPV vaccination on their sexual 
health.
Methods: A HPV questionnaire was completed by 357 UK-based adolescents, aged 12-13 
years. 
Results: Most adolescents knew HPV causes cervical cancer and HPV vaccination prevents 
this. A minority acknowledged HPV causes other genital cancers, with under a fifth knowing 
HPV causes genital warts. Adolescents  awareness of HPV transmission activities were limited. 
There was very poor awareness of oral HPV infection or HPV-induced oropharyngeal cancer. 
Half of the participants stated HPV vaccination reduced their concerns about STI contraction. 
Over half of males said they may take more sexual risks following vaccination, whilst a similar 
proportion of females did not expect their partner to take more risks. 
Conclusions: Adolescents had little awareness of male HPV infection and the role HPV 
vaccination can play in preventing these diseases. With variable rates of HPV vaccination 
uptake in males reported worldwide, this study indicates that in the UK greater emphasis on 
male HPV disease within educational information is required, to raise better awareness of 
how HPV affects both genders.  As both genders preferred to receive education via healthcare 
professionals, educating a wider-range of healthcare professionals on oral HPV could help 
facilitate awareness of HPV’s role in head and neck cancer.  
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KEY MESSAGES
 UK adolescents showed good awareness of HPV’s association with cervical cancer, but 
poor knowledge of other HPV-related diseases and the different transmission routes. 
 With more countries introducing HPV gender-neutral vaccination, HPV education 
should have an increased focus on HPV infection within male sexual health.
 Effective communication on oral HPV infection, including transmission routes and 
preventative measures, needs to be a key focus of healthcare polices.
 Enhanced education of healthcare professionals on oral HPV could help facilitate 
people’s awareness of HPV’s role in head and neck cancer.  
BACKGROUND/RATIONALE 
Human papillomavirus (HPV) is one of the most common sexually transmitted infections 
(STI)1, WHO estimates  291 million women worldwide harbour HPV, with sub-Sahara Africa, 
Latin America and Eastern Europe having the highest rates of infection2. HPV infection differs 
between ethnicities, with black people having the highest prevalence and is more common in 
men, with penile HPV prevalence double vaginal, with more men harbouring a high-risk HPV 
strain3. Although HPV is recognised as a genital infection, oral HPV infections are increasing 
with an average oral prevalence of 11.5% in men and 3.2% in females4. Oral HPV infections 
are linked with oral-genital and oral-anal sexual transmission, although oral-oral transmission, 
such as open-mouthed kissing/saliva transfer, has been indicated4,5.  
Infection with high-risk HPV strains are associated with genital and oropharynx cancers6,7. 
Globally, cervical is the most common HPV cancer6. However, worldwide increases in HPV 
oropharyngeal cancer (OPC), particularly in young men, means HPV-OPC is now the most 
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common HPV-related male cancer7. Predictions indicate by 2025, HPV-OPC will be more 
common than cervical cancer due to cervical screening, female-biased HPV vaccination, 
increasing rates of oral HPV and no early screening for HPV-OPC3,8.
Preventing HPV is difficult, transmission occurs by close contact, including touch, meaning an 
asymptomatic person can unwittingly spread infection7. The most effective prevention 
method is HPV vaccination, which is predominantly administered to women6 and, since 
introduction, has reduced female genital and oral HPV disease9-11. Increasing rates of male 
HPV-OPC and a reduction in oral and genital HPV infection in vaccinated men3,11 has led to 
currently 22 countries, including Australia, USA and 9 countries in Europe, extending the HPV 
vaccination to men11. In August 2018, after recommendation by the Joint Committee on 
Vaccination & Immunisation, the UK also agreed to offer gender-neutral HPV vaccination to 
help prevent more cases of HPV-related cancers, including HPV-OPC; with 12-13 year old male 
vaccination starting from September 201912.
Female vaccination uptake varies globally and is unlikely to reach the global target of 80% 
coverage2: due to limited awareness of HPV risks, sexual activity values, concerns around 
vaccination safety, and cost8-11. HPV vaccination administration also influences uptake, with 
a school-based delivery resulting, internationally, in higher vaccination uptake11,13. Male HPV 
vaccination rates differ greatly, with 80% in Australia11 compared to 56% in the US14, with an 
estimated 25 million US men eligible for HPV vaccination remaining unvaccinated3. Globally, 
adolescent male HPV vaccination is lower when compared to female vaccination at the same 
stage; which has been related to lack of male awareness of HPV15,16. Teenage boys show very 
limited knowledge regarding HPV in males16, with most parents unaware boys could receive 
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HPV vaccination17. Furthermore, this lack of knowledge around oral HPV is an issue regardless 
of age; a recent review indicated 1% of US adults knew HPV was a risk factor for OPC18.  
As a limited number of countries are offering gender-neutral HPV vaccination, better 
education on male HPV disease is seen as an important intervention strategy to increase 
people’s awareness of HPV-OPC and to positively influence male vaccination19. As such, it is 
imperative to understand males’ and females’ awareness of HPV to determine the 
effectiveness of current HPV educational material in informing both genders about HPV. 
Therefore, this study assessed the knowledge and perceptions of 12-13 year old adolescents 
regarding HPV, transmission routes and sourcing HPV educational information, to determine 
how to improve adolescents’ knowledge of the risks of genital and oral HPV infection. 
METHODS 
Design
This was an exploratory quantitative study, examining responses of school students to a series 
of HPV multiple-choice questions. To enable gender comparison the study adopted a 
between-participants design, comparing males and females on a series of dependent 
variables relating to knowledge of HPV diseases and vaccination, sources of HPV education 
used and would prefer to use, and attitudes to what vaccination meant to their sexual health 
choices.
Participants
Given the exploratory nature ideal sample size power calculations were not performed, the 
general aim was to obtain a representative sample of at least 300 participants from at least 
three schools, as has been obtained in similar studies22.
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After approval by the University of Derby’s Life Sciences Ethics Committee (16Sw0079) eight 
Secondary Education schools (11-16 year olds) within the Midlands, UK, were randomly 
approached to participate. Five, mixed gender state-controlled schools took part, from 2014-
2016.   All children aged 12-13 years, were provided with information for their main caregiver, 
explaining study aims and a consent form. Only children with a consent form signed by their 
caregiver participated, with an average participation rate of 52%. Caregivers supplied an 
identification number, which linked data collection to consent, ensuring anonymity. Data 
collection was performed up to 8 weeks after females had received their HPV vaccination. 
Materials
Data was collected using a questionnaire focused on HPV diseases and vaccination. Although 
there are validated HPV questionnaires18,20, we developed a new questionnaire, guided by 
other questionnaires20-21, due to the lack of pre-existing questionnaire for male and female 
12-13 year-olds that included oral HPV questions. The questionnaire was not designed as a 
psychometric scale to measure scores on particular constructs; it functioned as a series of 
individual questions, so factor analysis and measures of reliability such as Cronbach’s alpha 
are not applicable. The questionnaire employed closed questions with dichotomous or 
multiple-choice answers that young adolescents were able to understand without assistance 
and simple to answer during a fifty-minute lesson. 
Procedure
Data was collected in Personal, Health and Social Education (PHSE) lessons, which are used to 
educate UK children around sexual health. Students attended a designated HPV mixed gender 
lesson, in a class-room or school-hall, with the teacher in attendance. After an explanation of 
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the study’s aims, all participants completed the questionnaire individually. The research team 
monitored completion, addressing questions around clarity, but not providing answers.
After completion of the questionnaire, the research team gave an interactive session, as an 
incentive for school’s participation, around HPV diseases, vaccination and importance of 
cervical screening. 
Statistical methods 
Participants’ response to each option in the multiple-choice questions were obtained. 
Responses containing missing data (<2%) were excluded. Analyses were conducted using chi-
squared tests for independence to examine differences in responses between  genders 
(where expected frequencies were low Fisher’s exact tests were used).  Due to the large 
number of separate analyses, the alpha level was Bonferroni-adjusted to .001. Power analysis 
using G*Power still demonstrated high power (1 – β = .99) for a medium effect size (w = .3) 
following this adjustment. 
Patient and Public Involvement
PHSE teachers and school nurses helped ensured questionnaire suitability for young 
adolescents and were involved with recruitment. We would like to thank HPVaction.org and 
The Swallows Head & Neck charity for their contribution to this manuscript.  
RESULTS 
Data was recorded from 357 participants (129 males, 228 females, gender response rate 35% 
and 65% respectively) ). The overall percentage of participant response rate (number of actual 
participants compared to number of children in the year) for each school was: 
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 School 1= 41% (75/183)
School 2= 72% (81/113)
School 3 = 32% (45/148)
School 4 = 63% (68/108)
School 5= 63% (88/138).  
The majority of participants (84.2%) were white, with 6.8% mixed/multiple ethnic, 4.8% 
Asian/Asian British and 3.7% Black/Africa/Caribbean/Black British. Most participants stated 
no religion (56.3%) or were Christian (34.7%), with 3.6% identifying as Muslim, 1.7% Sikh, 
0.6% Hindu and the remaining 3.1% stated their religion as ‘other’.
Responses about HPV infection, diseases and vaccination, are in Table 1. Most participants 
were aware females could be infected with HPV, fewer participants were aware males could 
be infected, with a significantly higher proportion of females unaware of this (p<.001).
Table 1 
Adolescents’ knowledge about HPV. 
% (number) of Yes responses
Total
(N = 357) 
Male
(N = 129)
Female
(N = 228)
Gender 
comparison
p-value
Who can be infected with HPV?
Females 95.5 (341) 91.5 (118) 97.8 (223) .005
Males 53.8 (192) 66.7 (86) 46.5 (106) < .001*
What diseases can the HPV infection 
cause?
Cervical cancer 73.1 (261) 58.1 (75) 81.6 (186) < .001*
Penis cancer 31.7 (113) 42.6 (55) 25.4 (58) .001*
Anal cancer 24.9 (89) 30.2 (39) 21.9 (50) .082
Skin cancer 21.6 (77) 27.1 (35) 18.4 (42) .055
Genital warts 17.1 (61) 17.1 (22) 17.1 (39) .990
Mouth cancer 14.0 (50) 18.6 (24) 11.4 (26) .060
Skin warts 5.9 (21) 7.0 (9) 5.3 (12) .509
Mouth warts 5.6 (20) 7.8 (10) 4.4 (10) .184
None of the above 2.0 (7) 1.6 (2) 2.2 (5) >.999 a
What diseases can the HPV vaccination 
prevent?
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Cervical cancer 73.9 (264) 59.7 (77) 82.0 (187) < .001*
Penis cancer 33.6 (120) 45.0 (58) 27.2 (62) .001*
Anal cancer 26.1 (93) 36.4 (47) 20.2 (46) .001*
Skin cancer 18.5 (66) 19.4 (25) 18.0 (41) .744
Genital warts 16.5 (59) 20.9 (27) 14.0 (32) .092
Mouth cancer 15.4 (55) 16.3 (21) 14.9 (34) .731
Skin warts 6.2 (22) 8.5 (11) 4.8 (11) .162
Mouth warts 5.3 (19) 7.0 (9) 4.4 (10) .295
None of the above 2.0 (7) 4.7 (6) 0.4 (1) .010 a 
What activities can spread HPV?
Sex 90.8 (324) 89.9 (116) 91.2 (208) .682
Kissing 20.2 (72) 16.3 (21) 22.4 (51) .168
Saliva 14.3 (51) 19.4 (25) 11.4 (26) .039
Giving birth 11.2 (40) 17.1 (22) 7.9 (18) .008
Touch 10.1 (36) 10.1 (13) 10.1 (23) .998
None of the above 0.6 (2) 0.0 (0) 0.9 (2) .537 a
How can you prevent becoming 
infected with HPV?
Use a condom 68.3 (244) 76.0 (98) 64.0 (146) .020
Have fewer sexual partners 31.4 (112) 31.0 (40) 31.6 (72) .911
Not touch infected person 19.6 (70) 21.7 (28) 18.4 (42) .453
Never have sex 15.1 (54) 16.3 (21) 14.5 (33) .647
Do not take drugs 14.6 (52) 24.0 (31) 9.2 (21) < .001*
Do not smoke 14.3 (51) 20.2 (26) 11.0 (25) .017
Do not drink alcohol 10.9 (39) 14.7 (19) 8.8 (20) .083
Only have sex once married 5.3 (19) 7.0 (9) 4.4 (10) .295
All comparisons analysed using chi-squared tests unless otherwise indicated.
a Fisher’s exact test   * p ≤ .001
The majority of participants agreed HPV causes cervical cancer and HPV vaccine prevents 
cervical cancer, with female agreement significantly higher. Males were more aware HPV 
causes penis cancer and HPV vaccination can prevent this. Adolescents showed lower 
awareness of anal cancer although significantly more males agreed HPV vaccination could 
prevent this disease. Only a sixth of the cohort knew HPV vaccination prevents genital warts.
The cohort did not recognise the association of HPV with oral warts, with only 5.6% and 14.0% 
knowing HPV causes mouth warts and mouth cancer respectively. There was concomitantly 
low agreement regarding HPV vaccination preventing these diseases.
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Nearly all adolescents were aware of HPV’s spread by sex but other transmission activities 
were much less appreciated (Table 1). Both genders were largely unaware of HPV 
transmission by touch.
Condom usage was seen as the main preventative HPV measure, with the known preventive 
measure of fewer sexual partners selected by under a third of the cohort. Adolescent males 
appeared more aware of other HPV transmission activities such as drug taking (p<.001) and 
smoking.
When asked what HPV vaccination meant for their sexual health there were some clear 
gender differences. Both genders (73.7%) felt vaccination reminded them of STI risks, with 
just over half of participants feeling the vaccination reduced their concerns about contracting 
an STI. A significantly greater proportion of males agreed HPV vaccination may lead to taking 
more sexual risks that could expose them to STIs, (M=55.1%; F=24.5%, p<.001). However, 
when asked if they felt their partner may take more sexual risks, agreement was similar 
between genders (M=41.6%; F=39.4%) though significantly more females replied in the 
negative (M =33.6%; F=55.1%), with a greater proportion of males replying, “don’t know” 
(M=24.8%; F=5.6%, p<.001).
Only 20.2% of participants reported researching HPV or the vaccination. The use of health 
oriented educational sources, talking to parents or reading the educational leaflet schools 
provide appeared the most common choices (Figure 1). When asked the most preferred 
source for obtaining information (Figure 2), a lesson with a health care professional was the 
most popular choice for both genders followed by lessons with school nurse for males and 
with a teacher for females. Neither gender were interested in sourcing information from 
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healthcare websites, with the current UK use of providing an educational leaflet poorly 
received, particularly by males. 
DISCUSSION 
Males’ perception of HPV’s impact on their health is rarely determined, even though more 
males harbour HPV infections3,4. Furthermore, understanding of HPV and vaccination within 
the cohort being vaccinated, young adolescents is seldom studied. This study investigated 
gender difference in 12-13 year olds’ understanding around HPV diseases and the 
effectiveness of HPV education in informing adolescents about sexual health. 
The observations that both genders were aware of HPVs association with cervical cancer, with 
males having lower awareness, and both genders having limited awareness of HPV causing 
other cancers, confirms other studies16-24. Our cohort’s poor knowledge that HPV causes 
warts also ratifies other studies21-23. 
A concerning finding was the cohort’s ignorance of HPV’s links with oropharyngeal cancer, 
with less than one-sixth aware HPV vaccination could help reduce HPV-OPC. As with 
adolescent girls10-11, the boys’ knowledge was focused on infection and prevention methods 
associated with genital STI transmission, with both genders feeling sex was the predominant 
transmission route. Adolescents’ awareness of oral routes of HPV transmission has not been 
previously described. The incidence of performing oral sex is increasing, with 70% of UK 16-
24 year olds undertaking this practice25. Young people view oral sex as being risk-free in 
relation to pregnancy and STI transmission, with teenagers more likely to undertake oral sex 
than genital and most performing un-protected oral sex25,26. As HPV is transmitted by an oral-
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genital route, our study shows that oral HPV transmission needs to be better communicated 
and educational material to have a stronger emphasis towards non-genital HPV disease.  
More male focused HPV education is important when you consider our study showed a  
gender difference in relation to future sexual practices, with more males stating they may 
take more sexual risks due to HPV vaccination. The influence of HPV vaccination has no impact 
on sexual behaviour of young adults10,28,29. However, with both genders now receiving HPV 
vaccination our study shows that HPV vaccination limitations of STI protection needs to be 
better communicated, particularly to young men. 
Our study found very few adolescents researched HPV and HPV vaccination. Our female 
participants had all received the HPV vaccination and so had received a HPV educational 
leaflet. As very few females had read this leaflet and our participants’ low HPV knowledge is 
comparable to other studies, it would appear the use of educational HPV leaflets had minimal 
influence on our adolescents’ knowledge. 
Our participants, regardless of gender, stated they would most like to receive HPV education 
via a healthcare professional, rather than receiving educational leaflets which the UK health 
system currently provide to educate 12-13 year old children on HPV disease and  vaccination. 
The use of healthcare professionals is a proven route to increase HPV awareness regardless 
of age, gender and prior knowledge18,30 and our study confirms the need to educate the 
people adolescents feel more comfortable in approaching, rather than expecting young 
people to undertake independent sexual health education30. 
With vaccination uptake positively associated with increased HPV knowledge18, expanding 
and enhancing HPV education to a range of healthcare professionals whom the general 
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population seek advice from, such as dentists27 and pharmacists, would enable a more 
comprehensive approach to raising HPV disease awareness. This HPV education could be 
delivered as Continual Professional Development (CPD) with a gender-neutral approach to 
HPV disease and an enhanced focus on oral HPV, explaining the impact of gender-neutral 
vaccination on sexual health.
Our study has some limitations. Participants were from Midlands schools so not 
geographically diverse; however, the schools had   representative ethnicity profiles, so are 
broadly generalizable to the UK. The participation rate varied between each school, even 
though each school was proactive in encouraging students to obtain caregiver consent. 
Furthermore, more females than males took part in the study, due to less males returning 
signed consent forms. The questionnaire was not validated in the same manner as a 
psychometric scale, with the use of dichot mous and multiple-choice responses potentially 
problematic, as participants could select numerous responses to provide apparently correct 
answers. However, this design allowed for rapid data collection and easier coding than open 
questions. Despite these limitations, the overall findings of HPV knowledge of our UK 
participants align with similar worldwide HPV studies and our study is one of the first 
examining oral HPV knowledge in adolescents and for both genders, and can inform future 
global studies on less gender-biased HPV education. 
To conclude, both genders knowledge of HPV disease was poor and was mainly focused on 
cervical cancer. Both genders were less aware of male HPV disease, reducing young males’ 
awareness of the consequence of HPV infection on their sexual health. As HPV ignorance 
reduces vaccination uptake, educational material accentuating HPV in males, and how 
vaccination will reduce HPV prevalence, could positively influence male HPV vaccination 
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uptake. Greater awareness around oral HPV and HPV-OPC is also essential. As both genders 
preferred sourcing HPV education from a healthcare professional, more gender-neutral 
education on HPV provided to a range of healthcare professionals could help inform the 
general population on HPV disease in both genders. 
The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of 
all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis to 
the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published in 
BMJ SRH editions and any other BMJPGL products to exploit all subsidiary rights.
Competing Interests: None to declare
Contributorship statement: 
The lead author Dr Gillian Knight, contributed to the content of this manuscript by: designing the HPV 
questionnaire and consent forms, obtaining ethical approval, recruitment of schools and the data 
collection within schools. She wrote the original draft of the introduction and discussion sections of 
the manuscript. 
The co-author, Dr Ben Roberts undertook the data analysis of the questionnaire, which included the 
correct coding of the questionnaire for SPSS analysis, performing statistical analysis and presentation 
of the data. Dr Roberts also wrote the original draft of the methodology section of the manuscript.  
Dr Knight and Dr Roberts worked together to determine the key findings from the data analysis and 
then to write the original draft of the results section of the manuscript. 
They have also worked together to revise the manuscript after review and to respond to the reviewers 
comments. 
Page 16 of 21
https://mc.manuscriptcentral.com/bmjsrh
BMJ Sexual & Reproductive Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
15
Sensitivity: Internal
As part of the review requirements, the authors of this manuscript obtained contribution from 
HPVaction.org and The Swallows Head & Neck charity, in revising the original manuscript in 
accordance with reviewer’s comments. The Swallows Head & Neck charity required no amendments 
to the manuscript. HPVaction.org suggested a few minor amendments, which were incorporated in 
the revised manuscript. 
Page 17 of 21
https://mc.manuscriptcentral.com/bmjsrh
BMJ Sexual & Reproductive Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
16
Sensitivity: Internal
REFERENCES 
1. Chesson HW, Dunne EF, Hariri S, et al. The estimated lifetime probability of acquiring 
human papillomavirus in the United States. Sex Transm Dis 2014;41:660-4. 
doi:10.1097/OLQ.0000000000000193
2. Fahrion AS, Mikhailov A, Abela-Ridder B, et al. Weekly epidemiological record relevé 
épidémiologique hebdomadaire. World Health Organ 2016; 91:13-20.
3. Han JJ, Tarney CM, Song J. Variation in genital human papillomavirus infection 
prevalence and vaccination coverage among men and women in the USA. Future Oncol 
2017;13:1129-32. doi:10.2217/fon-2017-0147
4. Sonawane K, Suk R, Chiao EY, et al. Oral human papillomavirus infection: differences in 
prevalence between sexes and concordance with genital human papillomavirus 
infection, NHANES 2011 to 2014. Ann Intern Med 2017;167:714-24. doi:10.7326/M17-
1363
5. Martín-Hernán F, Sánchez-Hernández JG, Cano J, et al. Oral cancer, HPV infection and 
evidence of sexual transmission. Med Oral Patol Oral Cir Bucal 2013;18:e439-44. 
doi:10.4317/medoral.18419
6. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and 
related diseases. Vaccine 2012;30S:F12-23. doi:10.1016/j.vaccine.2012.07.055
7. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence 
rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013;31:4550-9. 
doi:10.1200/JCO.2013.50.3870
8. Ferrer HB, Trotter C, Hickman M, et al. Barriers and facilitators to HPV vaccination of 
young women in high-income countries: a qualitative systematic review and evidence 
synthesis. BMC Public Health 2014;14:700. doi:10.1186/1471-2458-14-700
9. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence 
among young women following HPV vaccine introduction in the United States, National 
Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013;208:385-93. 
doi:10.1093/infdis/jit192
10. Chaturvedi AK, Graubard BI, Broutian T, et al. Effect of prophylactic human 
papillomavirus (HPV) vaccination on oral HPV infections among young adults in the 
United States. J Clin Oncol 2018;36:262-7. doi:10.1200/JCO.2017.75.0141
11. Patel C, Brotherton JM, Pillsbury A, et al. The impact of 10 years of human 
papillomavirus (HPV) vaccination in Australia: what additional disease burden will a 
nonavalent vaccine prevent? Eurosurveillance 2018; 23. doi: 0.2807/1560-
7917.ES.2018.23.41.1700737
12. Public Health England. HPV vaccination Information for healthcare practitioners. 2019. 
Viewed at:  
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachm
ent_data/file/813014/PHE_HPV_universal_programme_guidance.pdf
13. Brabin L, Stretch R, Roberts SA, et al. The school nurse, the school and HPV vaccination: 
a qualitative study of factors affecting HPV vaccine uptake. Vaccine 2011; 12:3192-6 
doi.org/10.1016/j.vaccine.2011.02.038
14. Markowitz LE, Gee J, Chesson H et al. Ten years of human papillomavirus vaccination in 
the United States. Academic paediatrics 2018;18:S3-S10.doi:10.1016/j.acap.2017.09.014
Page 18 of 21
https://mc.manuscriptcentral.com/bmjsrh
BMJ Sexual & Reproductive Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
17
Sensitivity: Internal
15. Reiter PL, Gilkey MB, Brewer NT. HPV vaccination among adolescent males: results from 
the National Immunization Survey-Teen. Vaccine 2013;31:2816-21. 
doi:10.1016/j.vaccine.2013.04.010
16. Prue G, Shapiro G, Maybin R, et al. Knowledge and acceptance of human papillomavirus 
(HPV) and HPV vaccination in adolescent boys worldwide: a systematic review. J Cancer 
Pol 2016;10:1-15. doi:10.1016/j.jcpo.2016.09.009
17. Reiter PL, Stubbs B, Panozzo CA, et al. HPV and HPV vaccine education intervention: 
effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev 
2011;20:2354-61. doi:10.1158/1055-9965.EPI-11-0562
18. Dodd RH, Waller J, Marlow LA. Human papillomavirus and head and neck cancer: 
psychosocial impact in patients and knowledge of the link – a systematic review. Clin 
Oncol 2016;28:421-39. doi:10.1016/j.clon.2016.02.012
19. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human 
papillomavirus in a racially diverse sample of young adults. J Adolesc Health 
2008;42:237-42. doi:10.1016/j.jadohealth.2007.08.022
20. McRee A, Brewer NT, Reiter PL, et al. The Carolina HPV Immunization Attitudes and 
Beliefs Scale (CHIAS): Scale development and associations with intentions to vaccinate. 
Sex Transm Dis 2010;37:234-9. doi:10.1097/OLQ.0b013e3181c37e15
21. Suzuki Y, Sukegawa A, Nishikawa A, et al. Current knowledge of and attitudes toward 
human papillomavirus-related disease prevention among Japanese: A large-scale 
questionnaire study. J Obstet Gynaecol Res 2019;45:994-1005. doi:10.1111/jog.13929
22. Ghazali S, Islahudin F, Ismail G. Awareness of Human Papillomavirus (HPV) among school 
children in Johor, Malaysia. Brit J Pharm Res 2017;19:1-7. doi:10.9734/JPRI/2017/37068
23. Marek E, Dergez T, Rebek-Nagy G, et al. Adolescents’ awareness of HPV infections and 
attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine 
in Hungary. Vaccine 2011;29:8591-8. doi:10.1016/j.vaccine.2011.09.018
24. Patel H, Jeve YB, Sherman SM, et al. Knowledge of human papillomavirus and the 
human papillomavirus vaccine in European adolescents: a systematic review. Sex Transm 
Infect 2016; 1;92:474-9. doi:10.1136/sextrans-2015-052341
25. Mercer CH, Tanton C, Prah P, et al. Changes in sexual attitudes and lifestyles in Britain 
through the life course and over time: findings from the National Surveys of Sexual 
Attitudes and Lifestyles (Natsal). The Lancet 2013; 382:1781-1794. doi: 10.1016/S0140-
6736(13)62035-8
26. Saini R, Saini S, Sharma S. Oral sex, oral health and orogenital infections. J Glob Infect Dis 
2010;2:57-62. doi:10.4103/0974-777X.59252
27. Thompson EL, Daley EM, Vamos CA, et al. Health literacy approaches to improving 
communication between dental hygienists and patients for HPV-related oral cancer 
prevention. J Dent Hyg 2017;91:37-45.
28. Brouwer AF, Delinger RL, Eisenberg MC, et al. HPV vaccination has not increased sexual 
activity or accelerated sexual debut in a college-aged cohort of men and women. BMC 
public health 2019; 19: 821. doi:10.1186/s12889-019-7134-1
29. Marlow LAV, Waller J, Evans REC, et al. Predictors of interest in HPV vaccination: a study 
of British adolescents. Vaccine 2009;27:2483-8. doi:10.1016/j.vaccine.2009.02.057
30. Herzog TJ, Huh WK, Downs LS, et al. Initial lessons learned in HPV vaccination. Gynecol 
Oncol 2008;109:S4-11. doi:10.1016/j.ygyno.2008.01.018
Page 19 of 21
https://mc.manuscriptcentral.com/bmjsrh
BMJ Sexual & Reproductive Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
18
Sensitivity: Internal
Figure 1: Sources adolescents used to obtain information about HPV and HPV vaccination.                                                                                                              
Figures shown are percentages of males and females who reported they had used the source to 
research HPV or HPV vaccination. Overall, 20.2% of each gender reported using one or more of these 
sources. Proportions of males and females were compared for each source using chi-squared tests, 
but there were no significant differences between genders (all p > .001).
Figure 2: Adolescents’ preferred sources to obtain information about HPV and HPV vaccination 
Figures shown are percentages of males and females who reported they would like to obtain 
information about HPV and HPV vaccination from the source. Overall, 93.8% of males and 97.1% of 
females selected one or more of these sources. Proportions of males and females were compared for 
each source using chi-squared tests, but there were no significant differences between genders (all p 
> .001).
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Figure 1: Sources adolescents used to obtain information about HPV and HPV vaccination.                           
                                                                                    
Figures shown are percentages of males and females who reported they had used the source to research 
HPV or HPV vaccination. Overall, 20.2% of each gender reported using one or more of these sources. 
Proportions of males and females were compared for each source using chi-squared tests, but there were no 
significant differences between genders (all p > .001). 
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Figure 2: Adolescents’ preferred sources to obtain information about HPV and HPV vaccination 
Figures shown are percentages of males and females who reported they would like to obtain information 
about HPV and HPV vaccination from the source. Overall, 93.8% of males and 97.1% of females selected 
one or more of these sources. Proportions of males and females were compared for each source using chi-
squared tests, but there were no significant differences between genders (all p > .001). 
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